Lackner Mark

EDGAR CIK 0001777413

Zentalis Pharmaceuticals, Inc. - ZNTL

Officer
Chief Scientific Officer
Direct Buys
0
$0
0 Shares
Direct Sells
2
($32,053)
-5,996 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
01/02/2025
01/03/2025
Sell
-4,411 @ $3.12
($13,762) 191,317 (-2.25%) Direct
02/02/2024
02/05/2024
Sell
-1,585 @ $11.54
($18,291) 195,728 (-0.80%) Direct